Literature DB >> 12198044

Propofol-sufentanil anesthesia for thyroid surgery: optimal concentrations for hemodynamic and electroencephalogram stability, and recovery features.

Elisabeth Hentgen1, Malik Houfani, Valérie Billard, Florent Capron, Jean-Marc Ropars, Jean Paul Travagli.   

Abstract

UNLABELLED: Hypnotics and opioids interact synergistically to block responses to surgery and different dose combinations may be used to provide adequate anesthesia. In this study, we sought to determine the optimal concentrations of propofol and sufentanil, given by target-controlled infusions, to ensure hemodynamic stability, adequate hypnosis (assessed by electroencephalogram bispectral index), and fast recovery for a moderately painful operation. Forty-five patients, ASA physical status I or II, undergoing thyroidectomy, were randomly assigned to a sufentanil target concentration (STC) that was maintained throughout surgery (0.1, 0.2, or 0.3 ng/mL). The propofol target concentration was adjusted to keep mean arterial blood pressure within 30% of a reference value, and bispectral index between 40 and 60. Adequate anesthesia was obtained in all groups. Hypertension and clinically dangerous movements were more frequent with the small STC, and hypotension requiring treatment was more frequent with the large STC. Propofol target concentration during surgery decreased significantly with increasing STC (median at thyroid removal 5.0, 4.0, and 2.5 microg/mL, respectively) as well as the propofol consumption (740, 668, 474 mg/h). The 0.3 ng/mL STC significantly delayed the return of spontaneous breathing. IMPLICATIONS: Given as a target-controlled infusion for thyroid surgery, sufentanil 0.3 ng/mL for intubation and 0.2 ng/mL during surgery, combined with propofol 4 microg/mL (corresponding to a maintenance infusion rate of approximately 7-10 mg. kg(-1). h(-1)), is recommended to ensure both optimal intraoperative stability and fast recovery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12198044     DOI: 10.1097/00000539-200209000-00019

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  7 in total

1.  Total Intravenous Anesthesia-Target Controlled Infusion for colorectal surgery. Remifentanil TCI vs sufentanil TCI.

Authors:  Horaţiu Nicolae Vasian; Simona Mărgărit; Daniela Ionescu; Anamaria Keresztes; Bogdan Arpăşteuan; Nicoleta Condruz; Camelia Coadă; Iurie Acalovschi
Journal:  Rom J Anaesth Intensive Care       Date:  2014-10

2.  Comparison of total intravenous anaesthesia using propofol with or without sufentanil in laparoscopic cholecystectomies.

Authors:  M Subrahmanyam; B Sreelakshmi
Journal:  Indian J Anaesth       Date:  2009-08

3.  Confounding factors to predict the awakening effect-site concentration of propofol in target-controlled infusion based on propofol and fentanyl anesthesia.

Authors:  Shun-Ming Chan; Meei-Shyuan Lee; Chueng-He Lu; Chen-Hwan Cherng; Yuan-Shiou Huang; Chun-Chang Yeh; Chan-Yang Kuo; Zhi-Fu Wu
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

4.  Anesthetic management of primary hyperparathyroidism: A role rarely noticed and appreciated so far.

Authors:  Sukhminder Jit Singh Bajwa; Vishal Sehgal
Journal:  Indian J Endocrinol Metab       Date:  2013-03

5.  Effects of different doses of sufentanil and remifentanil combined with propofol in target-controlled infusion on stress reaction in elderly patients.

Authors:  Li-Guo Hu; Jian-Hui Pan; Juan Li; Fang Kang; Ling Jiang
Journal:  Exp Ther Med       Date:  2013-01-17       Impact factor: 2.447

6.  Anesthesia and thyroid surgery: The never ending challenges.

Authors:  Sukhminder Jit Singh Bajwa; Vishal Sehgal
Journal:  Indian J Endocrinol Metab       Date:  2013-03

Review 7.  Clinical Pharmacokinetics and Pharmacodynamics of Propofol.

Authors:  Marko M Sahinovic; Michel M R F Struys; Anthony R Absalom
Journal:  Clin Pharmacokinet       Date:  2018-12       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.